|
2014 Conference Publication Recommendations for Serum Free Light Chains (Sflc) Measurement in Routine LaboratoriesTate, Jill, Jovanovich, Sue, Mollee, Peter, Chiu, Weldon, Wienholt, Louise, Gillis, David, Reibelt, Lindsay and Youdell, Odette (2014). Recommendations for Serum Free Light Chains (Sflc) Measurement in Routine Laboratories. Unknown, Unknown, Unknown. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. |
|
2014 Journal Article How to diagnose amyloidosisMollee, P., Renaut, P., Gottlieb, D. and Goodman, H. (2014). How to diagnose amyloidosis. Internal Medicine Journal, 44 (1), 7-17. doi: 10.1111/imj.12288 |
|
2014 Conference Publication New diagnostic strategies for assessment of amyloidosis and myelomaMollee, Peter (2014). New diagnostic strategies for assessment of amyloidosis and myeloma. 48th Annual Scientific Meeting of the Australasian Division of the IAP, Brisbane, QLD Australia, 31 May – 2 June 2024. Oxford, United Kingdom: Elsevier. doi: 10.1097/01.pat.0000443473.89668.b2 |
|
2013 Journal Article Evaluation of the N Latex free light chain assay in the diagnosis and monitoring of AL amyloidosisMollee, Peter, Tate, Jill and Pretorius, Carel J. (2013). Evaluation of the N Latex free light chain assay in the diagnosis and monitoring of AL amyloidosis. Clinical Chemistry and Laboratory Medicine, 51 (12), 2303-2310. doi: 10.1515/cclm-2013-0361 |
|
2013 Conference Publication Diagnosis of amyloidosis subtype by laser-capture microdissection (LCM) and tandem mass spectrometry (MS) proteomic analysisMollee, Peter, Renaut, Patricia, Boros, Samuel, Loo, Dorothy and Hill, Michelle (2013). Diagnosis of amyloidosis subtype by laser-capture microdissection (LCM) and tandem mass spectrometry (MS) proteomic analysis. 55th ASH Annual Meeting, New Orleans, LA United States, 7-10 December 2013. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood.v122.21.5295.5295 |
|
2013 Conference Publication Diagnosis Of Amyloidosis Subtype By Laser-Capture Microdissection (LCM) and Tandem Mass Spectrometry (MS) Proteomic AnalysisMollee, Peter, Renaut, Patricia, Boros, Samuel, Loo, Dorothy and Hill, Michelle (2013). Diagnosis Of Amyloidosis Subtype By Laser-Capture Microdissection (LCM) and Tandem Mass Spectrometry (MS) Proteomic Analysis. 55th Annual Meeting of the American-Society-of-Hematology, New Orleans La, Dec 07-10, 2013. WASHINGTON: AMER SOC HEMATOLOGY. |
|
2013 Conference Publication Serum levels Of CD178 (Soluble FasL) predict treatment response and survival in chronic lymphocytic leukaemia (CLL)Mollee, Peter, Burgess, Melinda, McMillan, Nigel, Saunders, Nicholas, Cheung, Catherine, Hallek, Michael and Gill, Devinder S (2013). Serum levels Of CD178 (Soluble FasL) predict treatment response and survival in chronic lymphocytic leukaemia (CLL). 55th ASH Annual Meeting, New Orleans, LA, 7-10 December 2013. American Society of Hematology. doi: 10.1182/blood.v122.21.2866.2866 |
|
2013 Conference Publication Rapid Molecular Diagnosis Of JAK2V617F Negative MPN By Targeted Deep Sequencing Using The Ion Torrent PGMKlose, Nathan, Tallack, Michael R, Magor, Graham, Mollee, Peter and Perkins, Andrew C (2013). Rapid Molecular Diagnosis Of JAK2V617F Negative MPN By Targeted Deep Sequencing Using The Ion Torrent PGM. 55th ASH Annual Meeting, New Orleans, LA, 7-10 December 2013. American Society of Hematology. doi: 10.1182/blood.v122.21.4093.4093 |
|
2013 Journal Article CD62L as a therapeutic target in chronic lymphocytic leukemiaBurgess, Melinda, Gill, Devinder, Singhania, Richa, Cheung, Catherine, Chambers, Lynne, Renyolds, Brent A., Smith, Louise, Mollee, Peter, Saunders, Nicholas and McMillan, Nigel A. J. (2013). CD62L as a therapeutic target in chronic lymphocytic leukemia. Clinical Cancer Research, 19 (20), 5675-5685. doi: 10.1158/1078-0432.CCR-13-1037 |
|
2013 Journal Article Towards improved measurement of serum free light chains: clinical and laboratory issuesTate, Jill and Mollee, Peter (2013). Towards improved measurement of serum free light chains: clinical and laboratory issues. Biochimica Clinica, 37 (5), 395-404. |
|
2013 Journal Article Addition of etoposide to standard acute myeloid leukaemia induction chemotherapy does not improve survivalJackson, K., Mollee, P., Morris, K. and Kennedy, G. (2013). Addition of etoposide to standard acute myeloid leukaemia induction chemotherapy does not improve survival. Internal Medicine Journal, 43 (8), 953-954. doi: 10.1111/imj.12218 |
|
2013 Journal Article Using HitAlert flow cytometry to detect heparin-induced thrombocytopenia antibodies in a tertiary care hospitalSolano, Connie, Mutsando, Howard, Self, Marlene, Morel-Kopp, Marie-Christine and Mollee, Peter (2013). Using HitAlert flow cytometry to detect heparin-induced thrombocytopenia antibodies in a tertiary care hospital. Blood Coagulation & Fibrinolysis, 24 (4), 365-370. doi: 10.1097/MBC.0b013e32835cc17e |
|
2013 Journal Article Outcomes and prognostic factors for patients with acute myeloid leukemia admitted to the intensive care unitJackson, Kathryn, Mollee, Peter, Morris, Kirk, Butler, Jason, Jackson, Dwane, Kruger, Peter, Klein, Kerenaftali and Kennedy, Glen (2013). Outcomes and prognostic factors for patients with acute myeloid leukemia admitted to the intensive care unit. Leukemia and Lymphoma, 55 (1), 97-104. doi: 10.3109/10428194.2013.796045 |
|
2013 Conference Publication Serum Levels Of CD178 (Soluble FasL) Predict Treatment Response and Survival In Chronic Lymphocytic Leukaemia (CLL)Mollee, Peter, Burgess, Melinda, McMillan, Nigel, Saunders, Nicholas, Cheung, Catherine, Hallek, Michael and Gill, Devinder S. (2013). Serum Levels Of CD178 (Soluble FasL) Predict Treatment Response and Survival In Chronic Lymphocytic Leukaemia (CLL). 55th Annual Meeting of the American-Society-of-Hematology, New Orleans La, Dec 07-10, 2013. WASHINGTON: AMER SOC HEMATOLOGY. |
|
2013 Conference Publication Immunosuppression (IST) Can Be Safely Ceased During Chemotherapy For Post-Transplant Lymphoproliferative Disorders (PTLD) In Renal Transplant PatientsTaylor, Emma, Jones, Mark, Hourigan, Matthew J., Johnson, David W., Gill, Devinder S., Isbel, Nicole, Hawley, Carmel M., Marlton, Paula, Gandhi, Maher K., Campbell, Scott B. and Mollee, Peter (2013). Immunosuppression (IST) Can Be Safely Ceased During Chemotherapy For Post-Transplant Lymphoproliferative Disorders (PTLD) In Renal Transplant Patients. 55th Annual Meeting of the American Society of Hematology, New Orleans, LA United States, 7-10 December 2013. Washington, DC United States: American Society of Hematology. |
|
2012 Conference Publication Outcomes and prognostic factors for patients with acute myeloid leukemia admitted to the intensive care unitJackson, Kathryn A., Mollee, Peter, Morris, Kirk, Jackson, Dwane L., Kruger, Peter, Klein, Kerenaftali and Kennedy, Glen A. (2012). Outcomes and prognostic factors for patients with acute myeloid leukemia admitted to the intensive care unit. 54th ASH Annual Meeting, Atlanta, GA United States, 8-11 December 2012. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood.v120.21.3613.3613 |
|
2012 Conference Publication Intensive chemotherapy for acute myeloid leukemia in elderly patientsJackson, Kathryn A, Kennedy, Glen A, Mollee, Peter and Morris, Kirk (2012). Intensive chemotherapy for acute myeloid leukemia in elderly patients. 54th ASH Annual Meeting, Atlanta, GA, 8-11 December 2012. American Society of Hematology. doi: 10.1182/blood.v120.21.4341.4341 |
|
2012 Conference Publication Clinical comparison of the freelite and n-latex serum free light chain (FLC) assays in the diagnosis and monitoring of AL amyloidosisMapp, Sally, Tate, Jill, Pretorius, Carel and Mollee, Peter (2012). Clinical comparison of the freelite and n-latex serum free light chain (FLC) assays in the diagnosis and monitoring of AL amyloidosis. 54th ASH Annual Meeting, Atlanta, GA, 8-11 December 2012. WASHINGTON: American Society of Hematology. doi: 10.1182/blood.v120.21.4991.4991 |
|
2012 Journal Article Homozygous FCGR3A-158V alleles predispose to late onset neutropenia after CHOP-R for diffuse large B-cell lymphomaKeane, C., Nourse, J. P., Crooks, P., Nguyen-Van, D., Mutsando, H., Mollee, P., Lea, R. A. and Gandhi, M. K. (2012). Homozygous FCGR3A-158V alleles predispose to late onset neutropenia after CHOP-R for diffuse large B-cell lymphoma. Internal Medicine Journal, 42 (10), 1113-1119. doi: 10.1111/j.1445-5994.2011.02587.x |
|
2012 Journal Article CCL2 and CXCL2 enhance survival of primary chronic lymphocytic leukemia cells in vitroBurgess, Melinda, Cheung, Catherine, Chambers, Lynne, Ravindranath, Karunya, Minhas, Gunjeet, Knop, Louise, Mollee, Peter, McMillan, Nigel A. J. and Gill, Devinder (2012). CCL2 and CXCL2 enhance survival of primary chronic lymphocytic leukemia cells in vitro. Leukemia and Lymphoma, 53 (10), 1988-1998. doi: 10.3109/10428194.2012.672735 |
